Safety of ADU-1604 in Adults With Metastatic Melanoma
Status:
Terminated
Trial end date:
2019-08-09
Target enrollment:
Participant gender:
Summary
This study is a first-in-human, open-label, multicenter, dose-escalation study designed to
evaluate the safety, PK, and PD of ADU-1604 and explore initial clinical activity in adults
with metastatic melanoma.